U.S. federal trademark · Serial No. 79418919
Pharmaceutical drug development services in the fields of cancer, cardiovascular disease, and cell therapy, including stem cell therapy; research of pharmaceuticals to treat cancer, cardiovascular disease, and cell therapy, including stem cell therapy; research relating to cancer, cardiovascular disease, and cell therapy, including stem cell therapy; pharmaceutical research and development related to cancer, cardiovascular disease, and cell therapy, including stem cell therapy; research on the subject of pharmaceuticals for cancer, cardiovascular disease, and cell therapy, including stem cell therapy; pharmaceutical research services in the fields of cancer, cardiovascular disease, and cell therapy, including stem cell therapy; clinical research and conducting clinical trials in the fields of cancer, cardiovascular disease, and cell therapy, including stem cell therapy; conducting clinical trials for pharmaceutical products in the fields of cancer, cardiovascular disease, and cell therapy, including stem cell therapy; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for cancer, cardiovascular disease, and cell therapy, including stem cell therapy; providing information about the results of clinical trials for pharmaceutical products related to cancer, cardiovascular disease, and cell therapy, including stem cell therapy; pharmaceutical products development related to the treatment of cancer and cardiovascular disease; consulting services for others in the field of designing clinical trials related to cancer, cardiovascular disease, and cell therapy, including stem cell therapy; scientific and technical consulting and research services for the pharmaceutical industry in the fields of cancer, cardiovascular disease, and cell therapy, including stem cell therapy.
Custom manufacture of pharmaceuticals for the treatment of cancer.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.